Europe NK Cell Therapy Industry Market Report 2019

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 NK Cell Therapy Industry Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 NK Cell Therapies Market Performance (Volume)
  • 2.1.2 NK Cell Directed Antibodies Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 NK Cell Therapies Market Performance (Value)
  • 2.2.2 NK Cell Directed Antibodies Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Cancer Market Performance (Volume)
  • 3.1.2 Gastrointestinal Diseases Market Performance (Volume)
  • 3.1.3 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Nektar Therapeutics
  • 4.1.1 Nektar Therapeutics Profiles
  • 4.1.2 Nektar Therapeutics Product Information
  • 4.1.3 Nektar Therapeutics NK Cell Therapy Industry Business Performance
  • 4.1.4 Nektar Therapeutics NK Cell Therapy Industry Business Development and Market Status
• 4.2 Innate Pharma SA
  • 4.2.1 Innate Pharma SA Profiles
  • 4.2.2 Innate Pharma SA Product Information
  • 4.2.3 Innate Pharma SA NK Cell Therapy Industry Business Performance
  • 4.2.4 Innate Pharma SA NK Cell Therapy Industry Business Development and Market Status
• 4.3 Affimed
  • 4.3.1 Affimed Profiles
  • 4.3.2 Affimed Product Information
  • 4.3.3 Affimed NK Cell Therapy Industry Business Performance
  • 4.3.4 Affimed NK Cell Therapy Industry Business Development and Market Status
• 4.4 Chipscreen Biosciences
  • 4.4.1 Chipscreen Biosciences Profiles
  • 4.4.2 Chipscreen Biosciences Product Information
  • 4.4.3 Chipscreen Biosciences NK Cell Therapy Industry Business Performance
  • 4.4.4 Chipscreen Biosciences NK Cell Therapy Industry Business Development and Market Status
• 4.5 Fate Therapeutics
  • 4.5.1 Fate Therapeutics Profiles
  • 4.5.2 Fate Therapeutics Product Information
  • 4.5.3 Fate Therapeutics NK Cell Therapy Industry Business Performance
  • 4.5.4 Fate Therapeutics NK Cell Therapy Industry Business Development and Market Status
• 4.6 Glycostem Therapeutics
  • 4.6.1 Glycostem Therapeutics Profiles
  • 4.6.2 Glycostem Therapeutics Product Information
  • 4.6.3 Glycostem Therapeutics NK Cell Therapy Industry Business Performance
  • 4.6.4 Glycostem Therapeutics NK Cell Therapy Industry Business Development and Market Status
• 4.7 Dragonfly Therapeutics
  • 4.7.1 Dragonfly Therapeutics Profiles
  • 4.7.2 Dragonfly Therapeutics Product Information
  • 4.7.3 Dragonfly Therapeutics NK Cell Therapy Industry Business Performance
  • 4.7.4 Dragonfly Therapeutics NK Cell Therapy Industry Business Development and Market Status
• 4.8 Kiadis Pharma
  • 4.8.1 Kiadis Pharma Profiles
  • 4.8.2 Kiadis Pharma Product Information
  • 4.8.3 Kiadis Pharma NK Cell Therapy Industry Business Performance
  • 4.8.4 Kiadis Pharma NK Cell Therapy Industry Business Development and Market Status
• 4.9 NantWorks
  • 4.9.1 NantWorks Profiles
  • 4.9.2 NantWorks Product Information
  • 4.9.3 NantWorks NK Cell Therapy Industry Business Performance
  • 4.9.4 NantWorks NK Cell Therapy Industry Business Development and Market Status
• 4.10 Nkarta Therapeutics
  • 4.10.1 Nkarta Therapeutics Profiles
  • 4.10.2 Nkarta Therapeutics Product Information
  • 4.10.3 Nkarta Therapeutics NK Cell Therapy Industry Business Performance
  • 4.10.4 Nkarta Therapeutics NK Cell Therapy Industry Business Development and Market Status
• 4.11 Fortress Biotech

5 Market Performance for Manufacturers

• 5.1 Europe NK Cell Therapy Industry Sales (K Units) and Market Share by Manufacturers 2014-2020
• 5.2 Europe NK Cell Therapy Industry Revenue (M USD) and Market Share by Manufacturers 2014-2020
• 5.3 Europe NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
• 5.4 Europe NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.1.2 Germany NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.1.3 Germany NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.1.4 Germany NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.2.2 UK NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.2.3 UK NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.2.4 UK NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.3.2 France NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.3.3 France NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.3.4 France NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.4.2 Russia NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.4.3 Russia NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.4.4 Russia NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.5.2 Benelux NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.5.3 Benelux NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.5.4 Benelux NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.6.2 Italy NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.6.3 Italy NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.6.4 Italy NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.7.2 Spain NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.7.3 Spain NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.7.4 Spain NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.8.2 NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.8.3 NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
  • 6.8.4 NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
  • 6.8.5 Market Concentration

7 Europe NK Cell Therapy Industry Market Performance (Sales Point)

• 7.1 Europe NK Cell Therapy Industry Sales (K Units) and Market Share by Regions 2014-2020
• 7.2 Europe NK Cell Therapy Industry Revenue (M USD) and Market Share by Regions 2014-2020
• 7.3 Europe NK Cell Therapy Industry Price (USD/Unit) by Regions 2014-2020
• 7.4 Europe NK Cell Therapy Industry Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

• 8.1 Europe NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.2 Germany NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.3 UK NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.4 France NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.5 Russia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.6 Benelux NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.7 Italy NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.8 Spain NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Cancer Industry
• 11.2 Gastrointestinal Diseases Industry
• 11.3 Others Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 Europe NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 Europe NK Cell Therapy Industry Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 Germany NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 UK NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 France NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 Russia NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 Benelux NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Italy NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Spain NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
  • 12.2.1 Overall Market Performance
  • 12.2.2 NK Cell Therapies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.3 NK Cell Directed Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.3 Sales Forecast by Application 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Cancer Sales and and Growth Rate 2021-2026
  • 12.3.3 Gastrointestinal Diseases Sales and and Growth Rate 2021-2026
  • 12.3.4 Others Sales and and Growth Rate 2021-2026
• 12.4 Price (USD/Unit) and Gross Profit Forecast
  • 12.4.1 Europe NK Cell Therapy Industry Price (USD/Unit) Trend 2021-2026
  • 12.4.2 Europe NK Cell Therapy Industry Gross Profit Trend 2021-2026

13 Conclusion